A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation

Type of Cancer
Neuro-Oncology

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.